NASDAQ · Financial Statements
Biodexa Pharmaceuticals Plc (BDRX) Financial Statements
$1.71
NASDAQ: BDRX
Market Cap $1.28M
Overview Financials Dividend Biodexa Pharmaceuticals Plc most recently reported annual revenue of $0, net profit of $-6.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $1.0M $1.0M $0 $0 $0 Operating Profit $-7.0M $-9.0M $-8.0M $-9.0M $-8.0M Net Profit $-5.0M $-8.0M $-7.0M $-6.0M $-6.0M EPS $-4661590.00 $-4770680.00 $-69640.00 $-3705.65 $-400.00 Op Margin -1210.7% -1277.8% -2103.4% — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $13.0M $6.0M $11.0M $15.0M $18.0M Total Liabilities $2.0M $2.0M $6.0M $6.0M $7.0M Cash $10.0M $3.0M $6.0M $2.0M $9.0M Borrowings $1.0M $1.0M $0 $1.0M $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-6.0M $-7.0M $-7.0M $-12.0M $-5.0M Investing Cash Flow $-1.0M $0 $-1.0M $-1.0M $-1.0M Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $3.0M $-7.0M $3.0M $-4.0M $7.0M Free Cash Flow $-6.0M $-7.0M $-7.0M $-13.0M $-5.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 0.87 FCF Yield -590.77% Quick Ratio 2.03 Interest Coverage -72.31 Return 1Y -96.20% Return 3Y -99.98% Return 5Y -100.00%
Screens featuring this stock